Neuroblastoma — Trials

Neuroblastoma — Trials · CancerIndex

Clinical trials

Registered studies

616 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

Active: 137
Recruiting: 75
Ph III recruiting: 8
Growth YoY: −28%
Industry share: 8%
Top sponsor: National Cancer Institute (NCI)
Termination share: 34.2%

Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancers Terminated studies (80)

clinicaltrialsPublishedShowing 1–12 of 12 studies matching the filters · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT01586767	Intensity-Modulated or Proton Radiation Therapy for Sinonasal Malignancy	unknown	N/A	45	Massachusetts General HospitalOTHER	1	Sep 21, 2023	clinicaltrials
NCT05755295	Horse Therapy for Children, Adolescents and Young Adults in Remission From Medulloblastoma(EQUI-HIPPO)	unknown	N/A	15	University Hospital, ToulouseOTHER	1	Jul 13, 2023	clinicaltrials